Independent fund research. Built on SEC filings.

How we research funds

ETF · Target-Date · Vanguard

Vanguard Target Maturity 2028 Corporate Bond ETF (VBCB)

Ticker VBCB · Index fund · · Holdings as of Jun 30, 2026

Expense ratio
0.08%$8/yr per $10k
Net assets
$46.8Mall share classes
Holdings
651

Bottom line

Is VBCB a good fund? The bottom line

VBCB is an index target-date ETF from Vanguard.

It charges 0.08% — about $8 a year on every $10,000 invested, cheaper than 95% of target-date funds we track.

With $46.8 million in net assets and 651 holdings, its largest position is CVS Health Corp (0.7%) and the top 10 make up 6.1% of the portfolio.

What stands out

  • Low cost: cheaper than 95% of target-date peers
  • Broadly diversified (651 holdings)

What to watch

  • Small fund ($46.8 million) — small funds are likelier to close

Updated Nov 19, 2026

What VBCB invests in

Vanguard Target Maturity 2028 Corporate Bond ETF (the Fund) seeks to track the performance of a market-weighted index composed of U.S. dollar-dominated, investment-grade corporate bonds maturing in 2028.

The Fund employs an indexing investment approach designed to track the performance of the ICE 2028 Maturity US Corporate Constrained Index (the Target Index). The Target Index has a planned liquidation on or about December 15, 2028, and includes U.S. dollar-denominated, investment-grade corporate bonds scheduled to mature between January 1, 2028 and December 15, 2028. Under normal circumstances, the Fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the components of the Target Index or in securities determined by the Funds advisor to have economic characteristics substantially identical to those of the Target Index components. The Fund is a term fund that will liquidate on or about December 15, 2028 (the Planned Liquidation Date). The Fund does not seek to return any predetermined amount at liquidation or in periodic…

From the fund's prospectus (filed Mar 23, 2026).

What VBCB costs

On a $10,000 investment, VBCB's 0.08% expense ratio costs about $8 a year. The median target-date fund charges 0.59%.

See the full VBCB fee table →

VBCB top 10 holdings

#Holding% of fund
1CVS Health Corp0.72%
2Vanguard Cmt Funds-Vanguard Market Liquidity Fund0.70%
3Wells Fargo & Co0.63%
4Goldman Sachs Bank USA/New York NY0.59%
5Bank of America Corp0.59%
6JPMorgan Chase & Co0.58%
7Bank of America Corp0.58%
8Morgan Stanley0.58%
9Goldman Sachs Group Inc/The0.56%
10Cigna Group/The0.56%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 6.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to VBCB

More funds like VBCB →

VBCB FAQ

What is the expense ratio of VBCB?
VBCB's expense ratio is 0.08%, which works out to about $8 a year for every $10,000 invested.
Is VBCB a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 95% of target-date peers; broadly diversified (651 holdings); small fund ($46.8 million) — small funds are likelier to close. This is general information, not personalized advice.
What does VBCB hold?
VBCB's largest holdings are CVS Health Corp (0.7%), Vanguard Cmt Funds-Vanguard Market Liquidity Fund (0.7%), Wells Fargo & Co (0.6%), Goldman Sachs Bank USA/New York NY (0.6%), Bank of America Corp (0.6%). It holds 651 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
Who manages VBCB?
VBCB is offered by Vanguard through Vanguard Wellesley Income Fund.